EXAS vs VCTR · rev $2.76B vs P/E 14, rev $893.5M
EXACT Sciences Corporation (EXAS) versus Victory Capital Holdings Inc (VCTR) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Victory Capital Holdings Inc (VCTR) is a asset management company listed on US.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
Latest reported VCTR revenue for 2024-12-31 was $893.5M. Net income was $288.9M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. VCTR currently screens at market cap $4.35B and trailing P/E 14.4.
EXAS currently screens at market cap $20.03B. VCTR currently screens at market cap $4.35B and trailing P/E 14.4.
Not investment advice. Open the EXAS and VCTR stock pages for the full models.
Not investment advice.